Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101 — TREAT-ME 1

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Advanced Gastrointestinal Cancer Clinical Trial

Official title:
Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101

Status Terminated

Clinical Trial Summary

To evaluate the safety and tolerability of MSC_apceth_101.

n/a

See also
Status	Clinical Trial	Phase
Completed	`NCT01912131` - Person-Centered Oncology Care and Choices (P-COCC): Piloting and Initial Randomized Testing of a Combined Values Narrative Interview and Video Education Advance Care Planning Program in Gastrointestinal Oncology Patients	N/A
Completed	`NCT02024607` - A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer	Phase 1/Phase 2
Completed	`NCT02760199` - 89Zr-AMG211 PET Imaging Study	Phase 1
Completed	`NCT02677129` - Physical Function and Activities of Daily Living in Cancer Patients During Chemotherapy	N/A